Library

By /

Clear

Displaying 476 - 500 of 2,995

Advances in the Treatment of HER2+ Breast Cancer
Advances in the Treatment of HER2+ Breast Cancer
By: Mark Pegram, MD
HER-2 Disease: From NeoAdjuvant to Metastatic Setting
HER-2 Disease: From NeoAdjuvant to Metastatic Setting
By: Mark Pegram, MD
ctDNA Biomarkers to Drive Therapy
ctDNA Biomarkers to Drive Therapy
By: Massimo Cristofanilli, MD
Breast Cancer Screening – Updates in Breast Imaging
Breast Cancer Screening – Updates in Breast Imaging
By: Maxine Jochelson, MD, FSBI, FACR
  View PDF
Exosomes in Diagnosis and Treatment
Exosomes in Diagnosis and Treatment
By: Mickensone Andre, PhD
PI3K/AKT: Choices, Sequencing and New Agents
PI3K/AKT: Choices, Sequencing and New Agents
By: Neil Iyengar, MD
Who Needs Radiation Post Neoadjuvant Therapy
Who Needs Radiation Post Neoadjuvant Therapy
By: Nicolas Prionas, MD
Applying New Endocrine and Targeted Agents to the Treatment of Hormone Receptor Positive, HER2 Negative Breast Cancer
Applying New Endocrine and Targeted Agents to the Treatment of Hormone Receptor Positive, HER2 Negative Breast Cancer
By: Noridza Rivera-Rodriguez, MD
Bispecific/Biparatopic Antibodies in Breast Cancer (Zanidatimab, PM8002, etc)
Bispecific/Biparatopic Antibodies in Breast Cancer (Zanidatimab, PM8002, etc)
By: Paula Pohlmann, MD, PhD
Neoadjuvant Immunotherapy for Triple Negative Breast Cancer
Neoadjuvant Immunotherapy for Triple Negative Breast Cancer
By: Priyanka Sharma, MD
Escalation
Escalation
By: Quincy LaPlant, MD, PhD
  View PDF
Neoadjuvant with Antibody Drug Conjugates (ADC)
Neoadjuvant with Antibody Drug Conjugates (ADC)
By: Rebecca Shatsky, MD